By Dietrich Knauth NEW YORK (Reuters) - Purdue Pharma and its Sackler family owners have reached a new $7.4 billion settlement to resolve thousands of lawsuits alleging that the pain medication Oxycontin caused a widespread opioid addiction crisis in the U.S., Texas attorney general Ken Paxton said Thursday. The settlement was announced nearly seven months after the U.S. Supreme Court upended

New York's AG shared news of The Sackler family and Purdue Pharma settlement, while stating "no amount of money" could reverse the destruction caused.

The Sackler family and Purdue Pharma have agreed to pay $7.4 billion to resolve nationwide opioid litigation, marking a major milestone in efforts to hold the makers of the addictive pain medication OxyContin accountable for their role in the opioid crisis. This increased settlement, announced Thursday, follows the U.S. Supreme Court's June 2024 rejection of a prior deal and, if approved, will conclude the most expensive corporate bankruptcy...

The Sackler family has agreed to pay up to $6.5 billion over the span of 15 years.

A settlement reached with the Sackler family and Purdue Pharma will bring over $27 million to Delaware.